[1] |
Beniwal SS, Lamo P, Kaushik A, et al. Current status and emerging trends in colorectal cancer screening and diagnostics[J]. Biosensors(Basel), 2023,13:926. doi: 10.3390/bios13100926.
|
[2] |
Sayed AS, El Sayed NS. Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic acid potentiates the protective effect of celecoxib in lipopolysaccharide-induced cognitive impairment in mice: possible implication of anti-inflammatory and antiglutamatergic pathways[J].J Mol Neurosci, 2016, 59:58-67.
|
[3] |
Wu TT, Lu CL, Lin HI, et al. β-Elemonic acid inhibits the cell proliferation of human lung adenocarcinoma A549 cells: the role of MAPK, ROS activation and glutathione depletion[J]. Oncol Rep, 2016,35:227-234.
|
[4] |
Zhao A, Zhang Z, Zhou Y, et al. β-Elemonic acid inhibits the growth of human osteosarcoma through endoplasmic reticulum(ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression[J]. Phytomedicine, 2020, 6: 153-183.
|
[5] |
Yu T, An Q, Cao X L, et al. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway[J]. Life Sciences, 2020, 2: 118294. doi: 10.1016/j.lfs.2020.118294.
|
[6] |
Todorovic J, Stamenkovic Z, Stevanovic A, et al. The burden of breast, cervical, and colon and rectum cancer in the Balkan countries, 1990—2019 and forecast to 2030[J]. Arch Public Health, 2023, 24:81-156.
|
[7] |
Rega D, Granata V, Petrillo A, et al. Electrochemo-therapy of primary colon rectum cancer and local recurrence: case report and prospective analysis[J]. J Clin Med, 2022,11:2736-2745.
|
[8] |
Zhang Y, Yu YL, Tian H, et al. Evaluation of anti-inflammatory activities of a triterpene β-elemonic acid in frankincense in vivo and in vitro[J]. Molecules(Basel, Switzerland), 2019, 24: 1187-1193.
|
[9] |
Zhang Y, Cheng LY,et al. Development and validation of a sensitive UHPLC-MS/MS method for the measure-ment of β-elemonic acid in rat plasma and tissues and its application to pharmacokinetics and tissue distribution study[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2021,34:1167-1205.
|
[10] |
Glaviano A, Foo ASC, Lam HY, et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer[J]. Mol Cancer, 2023, 2: 138-143.
|
[11] |
Tian LY, Smit DJ, Jücker M. The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism[J]. Int J Mol Sci, 2023, 24: 2648-2652.
|
[12] |
Malinowsky K, Nitsche U, Janssen KP, et al. Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer[J]. Br J Cancer, 2014, 110: 2081-2089.
|
[13] |
Pan L, Cheng Y, Yang W, et al. Nintedanib ameliorates bleomycin-induced pulmonary fibrosis, inflammation, apoptosis, and oxidative stress by modulating PI3K/Akt/mTOR pathway in mice[J]. Inflammation, 2023, 46: 1531-1542.
|
[14] |
Unnisa A, Greig NH, Kamal MA. Inhibition of Caspase 3 and Caspase 9 mediated apoptosis: a multimodal therapeu-tic target in traumatic brain injury[J]. Curr Neuropharmacol, 2023, 21: 1001-1012.
|
[15] |
Zhang Y, Liang J, Cao N, et al. ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway[J]. BMC Cancer, 2022, 22: 778-7484.
|